{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:54:42Z","timestamp":1790841282474,"version":"4.1.0"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"\n Importance<\/jats:title>\n Although the Martin-Hopkins equation is widely validated and used to estimate low-density lipoprotein cholesterol (LDL-C) for clinical care, a simplified equation could streamline implementation and enable broader adoption.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To develop a simplified machine learning\u2013based alternative to the Martin-Hopkins equation using multivariate adaptive regression splines (LDL-C\u2013MH-MARS) and compare its performance with the Friedewald (LDL-C\u2013F), Sampson\u2013National Institutes of Health (LDL-C\u2013S), Modified Sampson (LDL-C\u2013MS), and Martin-Hopkins (LDL-C\u2013MH) equations.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n The Very Large Database of Lipids is a cross-sectional database of clinical lipid measurements from a population-representative convenience sample of adult and pediatric patients. Lipid measurements were performed by Vertical Auto Profile ultracentrifugation between October 1, 2015, and June 30, 2019. The study included patients with complete lipid panel data who were randomly assigned to a training set and a test set. External validation against preparative ultracentrifugation-based LDL-C measurements was performed in reference laboratory datasets from the Mayo Clinic (broad LDL-C concentrations) and the Further Cardiovascular Outcomes Research With Proprotein Convertase Subtilisin\/Kexin Type 9 (PCSK9) Inhibition in Subjects with Elevated Risk (FOURIER) trial (observations from patients with low LDL-C concentrations while taking evolocumab). Study data were analyzed from January to October 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n LDL-C\u2013F, LDL-C\u2013S, LDL-C\u2013MS, LDL-C\u2013MH, and LDL-C\u2013MH-MARS equations.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Accuracy of estimated vs ultracentrifugation-measured LDL-C concentration based on bias, root mean square error (RMSE), and concordance by guideline-based categories.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The study included 4\u202f939\u202f528 patients (mean [SD] age, 56 [16] years; 2\u202f635\u202f486 female [53%]) with complete lipid panel data who were randomly assigned to a training set (n\u2009=\u20093\u202f292\u202f889) and a test set (n\u2009=\u20091\u202f646\u202f639). LDL-C\u2013MH-MARS equation demonstrated a very low median (IQR) bias of \u22120.1 (\u22122.1 to 1.8) mg\/dL (to convert to millimoles per liter, multiply by 0.0259), comparable with LDL-C\u2013MH. The median (IQR) difference between the MARS and original Martin-Hopkins equations (ie, LDL-C\u2013MH-MARS \u2013 LDL-C\u2013MH) was \u22120.5 (\u22121.2 to 0) mg\/dL, further suggesting comparability between the 2 methods. The RMSE was smallest for LDL-C\u2013MH-MARS (4.7 mg\/dL) and LDL-C\u2013MH (4.9 mg\/dL), followed by LDL-C\u2013S (5.8 mg\/dL), LDL-C-MS (6.0 mg\/dL), and LDL-C\u2013F (7.2 mg\/dL). The proportion of patients correctly classified according to clinical categories was nearly identical for LDL-C\u2013MH-MARS (89.7%) and LDL-C\u2013MH (89.6%) but lower for LDL-C\u2013S (86.3%), LDL-C\u2013MS (84.7%), and LDL-C\u2013F (83.1%). The LDL-C\u2013MH-MARS, LDL-C\u2013MH, LDL-C\u2013MS, LDL-C\u2013S, and LDL-C\u2013F equations underestimated LDL-C concentration in 16%, 17%, 28%, 39%, and 60%, respectively, when classifying LDL-C less than 70 mg\/dL in patients with triglyceride concentrations of 200 to 399 mg\/dL (to convert to millimoles per liter, multiply by 0.0113). The patterns of results were similar in external validation datasets, with the LDL-C\u2013MH-MARS and LDL-C\u2013MH equations demonstrating the highest accuracy.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Study results suggest that the new machine learning\u2013based LDL-C equation provided results comparable with those of the original Martin-Hopkins method while simplifying implementation to a single equation.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2026.2314","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:00:48Z","timestamp":1784127648000},"page":"847","source":"Crossref","is-referenced-by-count":2,"title":["Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning"],"prefix":"10.1001","volume":"11","author":[{"given":"Jihwan","family":"Park","sequence":"first","affiliation":[{"name":"Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Fan","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Marzinke","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori J.","family":"Sokoll","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alagarraju","family":"Muthukumar","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina A.","family":"Murphy","sequence":"additional","affiliation":[{"name":"TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Sabatine","sequence":"additional","affiliation":[{"name":"TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Deputy Editor, JAMA Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Gurudu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff W.","family":"Meeusen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth S.","family":"Martin","sequence":"additional","affiliation":[{"name":"Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Johns Hopkins Department of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"19","key":"hoi260033r1","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines.","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"42","key":"hoi260033r2","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidemias.","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"issue":"18","key":"hoi260033r3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease.","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"21","key":"hoi260033r4","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1161\/CIRCULATIONAHA.121.056536","article-title":"Cardiovascular benefit of lowering low-density lipoprotein cholesterol below 40 mg\/dL.","volume":"144","author":"Marston","year":"2021","journal-title":"Circulation"},{"issue":"15","key":"hoi260033r5","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients.","volume":"388","author":"Nissen","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"hoi260033r6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2514428","article-title":"Evolocumab in patients without a previous myocardial infarction or stroke.","volume":"394","author":"Bohula","year":"2026","journal-title":"N Engl J Med"},{"issue":"3","key":"hoi260033r7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ajcp\/aqab153","article-title":"A tale of 2 approaches.","volume":"157","author":"Ghayad","year":"2022","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"hoi260033r8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5334\/gh.1214","article-title":"Accuracy of 23 equations for estimating LDL cholesterol in a clinical laboratory database of 5 051 467 patients.","volume":"18","author":"Samuel","year":"2023","journal-title":"Glob Heart"},{"issue":"19","key":"hoi260033r9","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile.","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"hoi260033r10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28817","article-title":"Comparison of methods to estimate low-density lipoprotein cholesterol in patients with high triglyceride levels.","volume":"4","author":"Sajja","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"12","key":"hoi260033r11","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.5551\/jat.35972","article-title":"Validity of a novel method for estimation of low-density lipoprotein cholesterol levels in diabetic patients.","volume":"23","author":"Chaen","year":"2016","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"hoi260033r12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148147","article-title":"Validation of the Martin method for estimating low-density lipoprotein cholesterol levels in Korean adults: findings from the Korea national health and nutrition examination survey, 2009-2011.","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"issue":"14","key":"hoi260033r13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003230","article-title":"Comparison and validation of 10 equations including a novel method for estimation of LDL-cholesterol in a 168 212 Asian population.","volume":"95","author":"Rim","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"hoi260033r14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4082\/kjfm.2017.38.5.263","article-title":"Martin\u2019s equation as the most suitable method for estimation of low-density lipoprotein cholesterol levels in Korean adults.","volume":"38","author":"Kang","year":"2017","journal-title":"Korean J Fam Med"},{"issue":"1","key":"hoi260033r15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.117.030677","article-title":"Fasting vs nonfasting and low-density lipoprotein cholesterol accuracy.","volume":"137","author":"Sathiyakumar","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"hoi260033r16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.repc.2020.11.011","article-title":"Applicability of Martin-Hopkins formula and comparison with Friedewald formula for estimated low-density lipoprotein cholesterol in e_COR study population.","volume":"40","author":"Ferrinho","year":"2021","journal-title":"Rev Port Cardiol (Engl Ed)"},{"issue":"8","key":"hoi260033r17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamacardio.2018.1533","article-title":"Comparison of low-density lipoprotein cholesterol assessment by Martin\/Hopkins estimation, Friedewald estimation, and preparative ultracentrifugation: insights from the FOURIER trial.","volume":"3","author":"Martin","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"2","key":"hoi260033r18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/ehjcvp\/pvac056","article-title":"Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidemia receiving cholesterol ester transfer protein inhibition.","volume":"9","author":"Martin","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"5","key":"hoi260033r19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jacl.2021.09.046","article-title":"Lipid measurements in the management of cardiovascular diseases: practical recommendations a scientific statement from the national lipid association writing group.","volume":"15","author":"Wilson","year":"2021","journal-title":"J Clin Lipidol"},{"issue":"4","key":"hoi260033r20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1515\/cclm-2019-1253","article-title":"Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.","volume":"58","author":"Langlois","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"hoi260033r21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5935\/abc.20170039","article-title":"Positioning about the Flexibility of Fasting for Lipid Profiling.","volume":"108","author":"Scartezini","year":"2017","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"hoi260033r23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia.","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"1","key":"hoi260033r24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/aos\/1176347963","article-title":"Multivariate adaptive regression splines.","volume":"19","author":"Friedman","year":"1991","journal-title":"Ann Statist"},{"issue":"11","key":"hoi260033r25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/clc.22214","article-title":"Very large database of lipids: rationale and design.","volume":"36","author":"Martin","year":"2013","journal-title":"Clin Cardiol"},{"issue":"4","key":"hoi260033r26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cll.2006.07.004","article-title":"Cholesterol profile measurement by vertical auto profile method.","volume":"26","author":"Kulkarni","year":"2006","journal-title":"Clin Lab Med"},{"issue":"6","key":"hoi260033r27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"11","key":"hoi260033r28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/clinchem\/hvaf073","article-title":"A modified Sampson-NIH equation with improved accuracy for estimating low levels of low-density lipoprotein-cholesterol.","volume":"71","author":"Sampson","year":"2025","journal-title":"Clin Chem"},{"key":"hoi260033r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2024.100649","article-title":"The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better.","volume":"18","author":"Mhaimeed","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"hoi260033r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106738","article-title":"Lipid lowering combination therapy: from prevention to atherosclerosis plaque treatment.","volume":"190","author":"Masana","year":"2023","journal-title":"Pharmacol Res"},{"issue":"14","key":"hoi260033r32","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology solution set oversight committee.","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"hoi260033r33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jacc.2013.01.079","article-title":"Friedewald-estimated vs directly measured low-density lipoprotein cholesterol and treatment implications.","volume":"62","author":"Martin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"hoi260033r34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cca.2022.10.003","article-title":"Comparability of calculated LDL-C with directly measured LDL-C in selected pediatric and adult cohorts.","volume":"537","author":"Steyn","year":"2022","journal-title":"Clin Chim Acta"},{"key":"hoi260033r35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117373","article-title":"Performance of equations for calculated LDL-C in hypertriglyceridemia: which one correlates best with directly measured LDL-C?","volume":"545","author":"Steyn","year":"2023","journal-title":"Clin Chim Acta"},{"key":"hoi260033r36","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14544","article-title":"Validation of low-density lipoprotein cholesterol equations in pediatric population.","volume":"11","author":"Ert\u00fcrk Zararsiz","year":"2023","journal-title":"PeerJ"},{"issue":"17-18","key":"hoi260033r37","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24963","article-title":"Correlation of extended Martin\/Hopkins equation with a direct homogeneous assay in assessing low-density lipoprotein cholesterol in patients with hypertriglyceridemia.","volume":"37","author":"Chung","year":"2023","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"hoi260033r38","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jacc.2021.11.042","article-title":"Discordance between standard equations for determination of LDL cholesterol in patients with atherosclerosis.","volume":"79","author":"Sajja","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi260033r39","doi-asserted-by":"publisher","first-page":"13545","DOI":"10.1038\/s41598-021-92625-x","article-title":"Comparison of the effectiveness of Martin\u2019s equation, Friedewald\u2019s equation, and a Novel equation in low-density lipoprotein cholesterol estimation.","volume":"11","author":"Song","year":"2021","journal-title":"Sci Rep"},{"key":"hoi260033r40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clinbiochem.2021.10.003","article-title":"Validating the NIH LDL-C equation in a specialized lipid cohort: does it add up?","volume":"99","author":"Higgins","year":"2022","journal-title":"Clin Biochem"},{"issue":"5","key":"hoi260033r41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263860","article-title":"Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.","volume":"17","author":"Ert\u00fcrk Zararsiz","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"hoi260033r42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/clinchem\/hvad190","article-title":"The Sampson-NIH equation is the preferred calculation method for LDL-C.","volume":"70","author":"Sampson","year":"2024","journal-title":"Clin Chem"},{"key":"hoi260033r43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cca.2018.11.022","article-title":"Deep neural network for estimating low density lipoprotein cholesterol.","volume":"489","author":"Lee","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"9","key":"hoi260033r44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239934","article-title":"Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation.","volume":"15","author":"Singh","year":"2020","journal-title":"PLoS One"},{"key":"hoi260033r45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cca.2021.02.020","article-title":"Estimation of low-density lipoprotein cholesterol by machine learning methods.","volume":"517","author":"Tsigalou","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"8","key":"hoi260033r46","doi-asserted-by":"publisher","DOI":"10.2196\/29331","article-title":"A deep neural network for estimating low-density lipoprotein cholesterol from electronic health records: real-time routine clinical application.","volume":"9","author":"Hwang","year":"2021","journal-title":"JMIR Med Inform"},{"key":"hoi260033r47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.cca.2021.05.008","article-title":"Is machine learning-derived low-density lipoprotein cholesterol estimation more reliable than standard closed form equations? insights from a laboratory database by comparison with a direct homogeneous assay.","volume":"519","author":"Barakett-Hamade","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"1","key":"hoi260033r48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/00045632211046805","article-title":"Machine learning predictive models of LDL-C in the population of eastern India and its comparison with directly measured and calculated LDL-C.","volume":"59","author":"P P","year":"2022","journal-title":"Ann Clin Biochem"},{"key":"hoi260033r49","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.824574","article-title":"Comparison of a machine learning method and various equations for estimating low-density lipoprotein cholesterol in Korean populations.","volume":"9","author":"Kwon","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"hoi260033r50","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/QAI.0000000000002869","article-title":"Machine learning estimation of low-density lipoprotein cholesterol in women with and without HIV.","volume":"89","author":"Dong","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"hoi260033r51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/labmed\/lmab065","article-title":"Estimation of low-density lipoprotein cholesterol concentration using machine learning.","volume":"53","author":"\u00c7ubuk\u00e7u","year":"2022","journal-title":"Lab Med"},{"key":"hoi260033r52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ijcard.2022.01.029","article-title":"Estimation of low-density lipoprotein cholesterol levels using machine learning.","volume":"352","author":"Oh","year":"2022","journal-title":"Int J Cardiol"},{"issue":"4","key":"hoi260033r53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/labmed\/lmad114","article-title":"Prediction of low-density lipoprotein cholesterol levels using machine learning methods.","volume":"55","author":"Kim","year":"2024","journal-title":"Lab Med"},{"key":"hoi260033r54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1129380","article-title":"On the importance of interpretable machine learning predictions to inform clinical decision-making in oncology.","volume":"13","author":"Lu","year":"2023","journal-title":"Front Oncol"},{"issue":"5","key":"hoi260033r55","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/clinchem\/hvad012","article-title":"The present and future of lipid testing in cardiovascular risk assessment.","volume":"69","author":"White-Al Habeeb","year":"2023","journal-title":"Clin Chem"},{"key":"hoi260033r29","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The Elements of Statistical Learning: Data Mining, Inference, and Prediction","author":"Hastie","year":"2009"},{"key":"hoi260033r22","unstructured":"Prieto? CC, Brice\u00f1o? I. Recomendaciones SMLC\u2014Perfil lip\u00eddico versi\u00f3n 2024. Accessed February 26, 2025. https:\/\/www.smlc.cl\/perfil-lipidico-2024"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2851049\/jamacardiology_park_2026_oi_260033_1788536075.77615.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:00:55Z","timestamp":1788966055000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2851049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2026.2314","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}